Trial Profile
Phase II Study of Postoperative Intensity-modulated Radiotherapy (IMRT) Combined With Capecitabine for Stage II/III Gastric Cancer Patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Sep 2023
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Adverse reactions
- 07 Sep 2012 New trial record